High cost is the primary barrier reported by physicians who prescribe vaccines not included in India's universal immunization program

Geoffrey D. Kahn, Deep Thacker, Somashekhar Nimbalkar, Mathuram Santosham

Research output: Contribution to journalArticle

Abstract

Haemophilus influenzae type B (Hib) vaccine, pneumococcal conjugate vaccine (PCV) and rotavirus (RV) vaccine are available in the private market in India, but, except for Hib in eight states, are not included in India's Universal Immunization Program (UIP). Pediatricians were surveyed about administering non-UIP vaccines. Most give these vaccines to some of their patients (73-83%, depending on vaccine), but few give them to all patients (7-18%). High cost was the most frequently cited barrier (93-96%). Only 10-12% of respondents had concerns about the efficacy of PCV or RV vaccine, and concerns about Hib vaccine efficacy or any vaccine safety issues were rare (1-3%). Practice varied by type of healthcare facility, with pediatricians at government hospitals least likely to administer non-UIP vaccines. Support for the inclusion of all three in the UIP was high (83-95%). Including Hib vaccine, PCV and RV vaccine in India's UIP would be supported by pediatricians and help eliminate the current barrier of high cost of these immunizations.

Original languageEnglish (US)
Article numberfmu012
Pages (from-to)287-291
Number of pages5
JournalJournal of Tropical Pediatrics
Volume60
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Immunization Programs
Haemophilus Vaccines
India
Rotavirus Vaccines
Vaccines
Conjugate Vaccines
Pneumococcal Vaccines
Physicians
Costs and Cost Analysis
Haemophilus influenzae
Immunization
Delivery of Health Care
Safety
Pediatricians

Keywords

  • Haemophilus vaccines
  • India
  • Pneumococcal vaccines
  • Rotavirus vaccines

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases
  • Medicine(all)

Cite this

High cost is the primary barrier reported by physicians who prescribe vaccines not included in India's universal immunization program. / Kahn, Geoffrey D.; Thacker, Deep; Nimbalkar, Somashekhar; Santosham, Mathuram.

In: Journal of Tropical Pediatrics, Vol. 60, No. 4, fmu012, 2014, p. 287-291.

Research output: Contribution to journalArticle

@article{af9eb3b26dfa48a5858b345865be71c0,
title = "High cost is the primary barrier reported by physicians who prescribe vaccines not included in India's universal immunization program",
abstract = "Haemophilus influenzae type B (Hib) vaccine, pneumococcal conjugate vaccine (PCV) and rotavirus (RV) vaccine are available in the private market in India, but, except for Hib in eight states, are not included in India's Universal Immunization Program (UIP). Pediatricians were surveyed about administering non-UIP vaccines. Most give these vaccines to some of their patients (73-83{\%}, depending on vaccine), but few give them to all patients (7-18{\%}). High cost was the most frequently cited barrier (93-96{\%}). Only 10-12{\%} of respondents had concerns about the efficacy of PCV or RV vaccine, and concerns about Hib vaccine efficacy or any vaccine safety issues were rare (1-3{\%}). Practice varied by type of healthcare facility, with pediatricians at government hospitals least likely to administer non-UIP vaccines. Support for the inclusion of all three in the UIP was high (83-95{\%}). Including Hib vaccine, PCV and RV vaccine in India's UIP would be supported by pediatricians and help eliminate the current barrier of high cost of these immunizations.",
keywords = "Haemophilus vaccines, India, Pneumococcal vaccines, Rotavirus vaccines",
author = "Kahn, {Geoffrey D.} and Deep Thacker and Somashekhar Nimbalkar and Mathuram Santosham",
year = "2014",
doi = "10.1093/tropej/fmu012",
language = "English (US)",
volume = "60",
pages = "287--291",
journal = "Journal of Tropical Pediatrics",
issn = "0142-6338",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - High cost is the primary barrier reported by physicians who prescribe vaccines not included in India's universal immunization program

AU - Kahn, Geoffrey D.

AU - Thacker, Deep

AU - Nimbalkar, Somashekhar

AU - Santosham, Mathuram

PY - 2014

Y1 - 2014

N2 - Haemophilus influenzae type B (Hib) vaccine, pneumococcal conjugate vaccine (PCV) and rotavirus (RV) vaccine are available in the private market in India, but, except for Hib in eight states, are not included in India's Universal Immunization Program (UIP). Pediatricians were surveyed about administering non-UIP vaccines. Most give these vaccines to some of their patients (73-83%, depending on vaccine), but few give them to all patients (7-18%). High cost was the most frequently cited barrier (93-96%). Only 10-12% of respondents had concerns about the efficacy of PCV or RV vaccine, and concerns about Hib vaccine efficacy or any vaccine safety issues were rare (1-3%). Practice varied by type of healthcare facility, with pediatricians at government hospitals least likely to administer non-UIP vaccines. Support for the inclusion of all three in the UIP was high (83-95%). Including Hib vaccine, PCV and RV vaccine in India's UIP would be supported by pediatricians and help eliminate the current barrier of high cost of these immunizations.

AB - Haemophilus influenzae type B (Hib) vaccine, pneumococcal conjugate vaccine (PCV) and rotavirus (RV) vaccine are available in the private market in India, but, except for Hib in eight states, are not included in India's Universal Immunization Program (UIP). Pediatricians were surveyed about administering non-UIP vaccines. Most give these vaccines to some of their patients (73-83%, depending on vaccine), but few give them to all patients (7-18%). High cost was the most frequently cited barrier (93-96%). Only 10-12% of respondents had concerns about the efficacy of PCV or RV vaccine, and concerns about Hib vaccine efficacy or any vaccine safety issues were rare (1-3%). Practice varied by type of healthcare facility, with pediatricians at government hospitals least likely to administer non-UIP vaccines. Support for the inclusion of all three in the UIP was high (83-95%). Including Hib vaccine, PCV and RV vaccine in India's UIP would be supported by pediatricians and help eliminate the current barrier of high cost of these immunizations.

KW - Haemophilus vaccines

KW - India

KW - Pneumococcal vaccines

KW - Rotavirus vaccines

UR - http://www.scopus.com/inward/record.url?scp=84905442612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905442612&partnerID=8YFLogxK

U2 - 10.1093/tropej/fmu012

DO - 10.1093/tropej/fmu012

M3 - Article

C2 - 24567310

AN - SCOPUS:84905442612

VL - 60

SP - 287

EP - 291

JO - Journal of Tropical Pediatrics

JF - Journal of Tropical Pediatrics

SN - 0142-6338

IS - 4

M1 - fmu012

ER -